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Introduction 
Discovered over 100 years ago, Klebsiella pneumoniae is a gram-negative pathogen found in the 
environment and on mammalian mucosal surfaces1. In the Western world, K. pneumoniae most 
commonly infects the lungs and urinary tract. The majority of these infections occurs in hospitals 
and long-term care facilities2. However, over the past 20 years, considerable attention has been 
focused on community-acquired pyogenic liver abscesses (CA-PLA) caused by a hypervirulent 
variant of K. pneumoniae with a tendency for metastatic spread2,3. Most of these cases have 
been reported from Taiwan, where this organism is the leading cause of PLA. Since the mid-
1980s, over 900 patients with PLA due to K. pneumoniae were reported from East and Southeast 
Asian countries. Nonetheless, K. pneumoniae CA-PLA is becoming a global issue as evidenced 
by confirmed cases in North America and Europe with the majority of hosts being of Asian 
descent. A total of fifteen cases of hypermucoviscous K. pneumoniae CA-PLA have been 
reported in the United States4-9. Purported theories for the stratified prevalence of K. 
pneumoniae pyogenic liver abscesses include genetic susceptibility, socioeconomic factors, and 
interaction between bacterial and host variables2. The hypermucoviscous strain of K. 
pneumoniae is an emerging phenotype with very critical distinguishing features. These include a 
community-acquired origin, absence of underlying hepatobiliary disease in the host, and invasive 
complications, such as meningitis, brain abscess, endophthalmitis, endovascular infections, and 
colon cancer. This report details the first reported case of hypermucoviscous K. pneumoniae CA-
PLA in the state of Missouri identified in an otherwise healthy individual of Asian descent. 
Case Presentation 
A 38 year-old Asian male with no previous medical diagnoses presented to the emergency 
department (ED) with right upper quadrant abdominal pain, headache, and myalgia. He denied 
recent abdominal surgery, biliary disease, diabetes mellitus, recent travel, or sick contacts. The 
patient was examined in the ED and discharged home with a diagnosis of viral syndrome. 
However, the patient’s symptoms became more severe and he returned to the ED three days later 
reporting fevers up to 102.5°F, a severe left-sided tension-type headache, pleuritic chest pain, 
dyspnea, and anorexia. 
The patient was born and raised in Burma and moved to Malaysia later in life. He emigrated 
from Malaysia to the United States 5 years ago and had not left the United States since then. He 
had no history of significant childhood illnesses. He reported recent contact with visitors from 
Thailand, who were all healthy at the time of interaction. 
Significant findings on physical examination included extreme tenderness to palpation of the 
right upper quadrant. Laboratory studies were remarkable for leukocytosis (WBC 12,100/mm3 
with 73.4% granulocytes and 11.9% monocytes), hyperbilirubinemia (1.4 mg/dL), mild 
transaminitis (ALT 63 U/L, ALP 166 U/L), and evidence of inflammation with an ESR of 57 
mm/hr and CRP of 9.1 mg/dL. Urinalysis was notable for amber colored urine, presence of 
bilirubin, 2.0 Ehrlich U/dL urobilinogen, 20-30 RBCs/hpf, 30mg/dL protein, and 15 mg/dL 
ketones. 
A CT of the abdomen and pelvis with intravenous contrast revealed a peripherally enhancing 
hypodense mass in hepatic segment IVa with no significant central enhancement on delayed 
phase imaging. Approximately 20 mL of purulent fluid was removed from the abscess via IR-
guided biopsy and drainage. An abscess drainage catheter was not introduced secondary to the 
high puncture with possibility of pleural reflection transgression. 
The patient was started on IV ceftriaxone and metronidazole, diagnostic testing was ordered, and 
an abscess gram stain and anaerobic culture was performed to identify the culprit pathogen. 
Results of diagnostic laboratory testing are as follows: 
HIV 1,2 Antigen Antibody: Nonreactive 
Cryptosporidium: Negative 
Giardia Antigen by EIA: Negative 
Stool ova and parasites :Negative 
Quantiferon-TB Gold: Negative 
Abscess culture – anaerobic Hypermucoviscous K. pneumonia 
 
Culture plate demonstrating the hypermucoviscous characteristics of the isolate. Strains of 
Klebsiella with the hypermucoviscosity phenotype are identified with the string test. A colony is 
lifted off the growing medium with an inoculation loop. A string greater than 5 mm is considered 
a positive result. 
On follow-up ultrasound of the right upper quadrant the following day, the liver abscess had not 
significantly changed in size compared with the initial CT scan. However, no new fluid 
collection or perihepatic free fluid was visualized and the patient’s headache and abdominal pain 
had improved. Another 20mL of purulent fluid was drained from the abscess and a silicon drain 
was placed. 
The patient was discharged on hospital day 7 on a six-week course of oral ciprofloxacin. Five 
days after discharge he presented to the clinic for follow up with his silicon drain in place. 
Symptomatically the patient seemed to be improving. However, since discharge, the patient was 
continuing to drain approximately 20 mL of fluid each day. A colonoscopy was scheduled in one 
month to screen for colorectal malignancy. 
Discussion 
This previously healthy 38 year-old patient initially presented to the hospital with symptoms 
consistent with a viral illness. However, worsening abdominal pain and fevers led to further 
workup and identification of a hepatic abscess of the right lobe. The patient’s history of 
inhabitance in Malaysia five years prior and an otherwise unremarkable past medical and social 
history increased suspicion for a primary pyogenic liver abscess caused by K. pneumoniae. 
Clinical features of pyogenic liver abscess include fever, chills, right upper quadrant tenderness, 
abdominal pain, leukocytosis, elevated ALT and AST, elevated ALP, and hyperbilirubinemia12. 
In the United States, pyogenic liver abscesses are most often polymicrobial with streptococci and 
Escherichia coli being the most common pathogens1. However, monomicrobial liver abscesses 
caused by Klebsiella pneumoniae infection have become more prominent in recent years 10. K. 
pneumoniae infection occurs most commonly in individuals with a compromised immune 
response, such as diabetes, malignancy, and alcoholism. It is also more common in patients with 
hepatobiliary disease, colorectal disease or a history of intraabdominal disease or trauma. K. 
pneumoniae can also occur in the absence of hepatobiliary disease11. 
The prevalence of hypermucoviscous K. pneumoniae CA-PLA in individuals of Asian descent is 
not well understood. It is hypothesized that an undetermined host genetic factor may predispose 
these individuals to intestinal colonization by more virulent strains of K. pneumoniae. It is 
posited that liver abscess may occur when this more virulent strain of bacteria translocates across 
the intestinal epithelium to the liver13. Interestingly, individuals colonized with this more 
virulent strain of K. pneumoniae do not always develop infection2. However, the associated risk 
factors, mechanisms of infection, and outcomes of K. pneumonia liver abscesses remain largely 
unclear. 
Studies have shown that the mucoviscosity-associated gene A (magA) and regulator of the 
mucoid phenotype A (rmpA) are the main contributors to the increased virulence of the 
hypermucoviscosity phenotype of K. pneumoniae that causes CA-PLA in Taiwan13,14. 
Specifically, magA+ K. pneumoniae strains demonstrate increased serum resistance, greater 
resistance to phagocytosis, and greater lethality in mice14. RmpA is a regulatory gene for the 
synthesis of the extracapsular polysaccharide and positively controls the mucoid phenotype of K. 
pneumoniae. Overproduction of polysaccharide is responsible for the mucoid phenotype of K. 
pneumoniae. The bacterial chromosome encodes the rmpA gene, but the mucoid phenotype itself 
is regulated by rmpA located in a plasmid13. In addition, this strain of K. pneumoniae can more 
efficiently acquire iron for the purposes of growth and replication. Overall, both rmpA and magA 
genes are essential for the induction of the hypermucoviscosity phenotype by K. pneumoniae. 
Thus far, only 15 cases of K. pneumoniae strains with the hypermucoviscosity phenotype have 
been reported in cases of CA-PLA in the United States5-9. Despite the small number of reports, 
the incidence of this disease is rising. Furthermore, more than one-third of individuals infected 
with hypermucoviscous strains of K. pneumoniae are more likely to develop complications, such 
as meningitis, endocarditis, subcutaneous muscular abscesses, osteomyelitis, pulmonary emboli, 
pleural empyema or endophthalmitis as compared than individuals infected with 
hypermucoviscous-negative strains2. Even more concerning is the finding that these serious, life-
threatening complications can develop in young, previously healthy individuals15. The current 
mortality rate for hypermucoviscous K. pneumoniae infection ranges from 3-42%2. Currently, 
this hypervirulent strain of K. pneumoniae remains uniformly resistant to ampicillin, but is 
susceptible to most antibiotics, including third and fourth-generation cephalosporins, 
monobactam, carbapenems, and ciprofloxacin2. However, it is possible that as the disease 
becomes more prominent, this stain will become resistant to antimicrobials leaving few options 
for treatment other than supportive care2,13,15. 
Conclusion 
We report the case of a 38 year-old previously healthy Burmese man who presented with 
abdominal pain, headache, myalgia, and back pain. He was found to have leukocytosis, 
transaminitis, hyperbilirubinemia, and evidence of systemic inflammation. A hypodense hepatic 
mass was identified with a CT of the abdomen. The patient was ultimately diagnosed with 
hypermucoviscous K. pneumoniae CA-PLA. 
This case provides additional evidence for the emergence of hypermucoviscous K. pneumoniae 
CA-PLA outside of East Asia and supports the need for continued research to gain a better 
understanding of its pathogenesis predilection for individuals of Asian decent. This report also 
delineates the importance of acknowledging the dynamic state of infectious disease, the shifting 
racial demographics in the Western world, and the ever-present potential for antibiotic resistance. 
With this information clinicians will be more equipped to identify and treat a potentially fatal 
disease in individuals with symptoms of a seemingly self-limiting infection. 
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 Introduction 
Osteoporosis occurs with increased prevalence in individuals with inflammatory bowel disease 
(IBD), and as such, these patients are at risk for osteoporosis-related fractures.   Although 
bisphosphonates remain the most commonly used class of drugs for managing osteoporosis, the 
effectiveness of oral bisphosphonates in patients with IBD may be diminished due to distressing 
gastrointestinal side effects, which hinder compliance, and also due to poor absorption by 
diseased intestine. 
While intravenous bisphosphonate therapy remains an option for these patients, denosumab has 
emerged in recent years as an alternative bone-modifying agent.  Denosumab received FDA 
approval for treatment of postmenopausal osteoporosis in 2010 and clinical trials have 
demonstrated that this medication is both efficacious and well tolerated.  Hypocalcemia is a 
known adverse effect of this medication, although in clinical trials, denosumab has been well 
tolerated, and numerous trials, most notably the FREEDOM trial (and its two-year extension 
trial), have failed to demonstrate a significant risk of hypocalcemia while receiving denosumab 
[1].  However, there have been no formal studies assessing for the risk of hypocalcemia while 
receiving denosumab in patients who have gastrointestinal disorders such as IBD.  This report 
details a patient with a history of corticosteroid-treated Crohn’s disease, who developed severe, 
symptomatic hypocalcemia shortly after beginning denosumab therapy. 
